Cross Country Healthcare Inc (NASDAQ:CCRN) Move as Institutional Investors’ Sentiment Up

June 12, 2018 - By Louis Casey

Sentiment for Cross Country Healthcare Inc (NASDAQ:CCRN)

Cross Country Healthcare Inc (NASDAQ:CCRN) institutional sentiment increased to 1.48 in 2018 Q1. Its up 0.59, from 0.89 in 2017Q4. The ratio is better, as 62 institutional investors started new and increased holdings, while 42 trimmed and sold holdings in Cross Country Healthcare Inc. The institutional investors in our partner’s database now hold: 32.76 million shares, up from 32.44 million shares in 2017Q4. Also, the number of institutional investors holding Cross Country Healthcare Inc in their top 10 holdings decreased from 1 to 0 for a decrease of 1. Sold All: 16 Reduced: 26 Increased: 46 New Position: 16.

Cross Country Healthcare, Inc. provides healthcare staffing, recruiting, and workforce solutions in the United States. The company has market cap of $434.98 million. The firm operates through three divisions: Nurse and Allied Staffing, Physician Staffing, and Other Human Capital Management Services. It has a 10.43 P/E ratio. The Nurse and Allied Staffing segment offers traditional staffing, including temporary and permanent placement of travel nurses and allied professionals, and branch local nurses and allied staffing; and short-term staffing of registered nurses, licensed practical nurses, certified nurse assistants, practitioners, pharmacists, and other allied professionals on per diem and short-term assignments.

The stock increased 0.50% or $0.06 during the last trading session, reaching $11.95. About 58,089 shares traded. Cross Country Healthcare, Inc. (NASDAQ:CCRN) has risen 7.47% since June 12, 2017 and is uptrending. It has underperformed by 5.10% the S&P500.

Analysts await Cross Country Healthcare, Inc. (NASDAQ:CCRN) to report earnings on August, 1. They expect $0.05 earnings per share, down 68.75 % or $0.11 from last year’s $0.16 per share. CCRN’s profit will be $1.82M for 59.75 P/E if the $0.05 EPS becomes a reality. After $0.06 actual earnings per share reported by Cross Country Healthcare, Inc. for the previous quarter, Wall Street now forecasts -16.67 % negative EPS growth.

Hawk Ridge Capital Management Lp holds 2.53% of its portfolio in Cross Country Healthcare, Inc. for 779,582 shares. Skyline Asset Management Lp owns 1.07 million shares or 0.96% of their US portfolio. Moreover, Eagle Boston Investment Management Inc has 0.81% invested in the company for 732,635 shares. The Massachusetts-based Aristotle Capital Boston Llc has invested 0.78% in the stock. Engaged Capital Llc, a California-based fund reported 491,669 shares.

Since January 1, 0001, it had 4 buys, and 1 insider sale for $138,353 activity.

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Ratings Coverage

Ratings analysis reveals 43% of Cross Country Healthcare’s analysts are positive. Out of 7 Wall Street analysts rating Cross Country Healthcare, 3 give it “Buy”, 0 “Sell” rating, while 4 recommend “Hold”. The lowest target is $13 while the high is $15. The stock’s average target of $15 is 25.52% above today’s ($11.95) share price. CCRN was included in 7 notes of analysts from February 1, 2018. The rating was downgraded by Cantor Fitzgerald on Friday, March 2 to “Neutral”. BMO Capital Markets maintained it with “Outperform” rating and $13 target in Tuesday, March 6 report. The company was maintained on Thursday, March 1 by SunTrust. The firm has “Hold” rating given on Thursday, March 1 by Benchmark. The stock of Cross Country Healthcare, Inc. (NASDAQ:CCRN) has “Hold” rating given on Friday, March 2 by Lake Street.

More news for Cross Country Healthcare, Inc. (NASDAQ:CCRN) were recently published by:, which released: “Consider Cross Country Healthcare” on June 05, 2018.‘s article titled: “TTEC (TTEC) & Cross Country Healthcare (NASDAQ:CCRN) Critical Analysis” and published on June 08, 2018 is yet another important article.

Cross Country Healthcare, Inc. (NASDAQ:CCRN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.